Skip Navigation

Johns Hopkins Bloomberg School of Public Health

Johns Hopkins Bloomberg School of Public Health: The INFO Project

Your knowledge-sharing resource on family planning and reproductive health

Universal Navigation:
INFO Home  |  Order  |  e-lists  |  Search Web Site  |  Contact Us  |  Press  |  Site Map  |  Espaņol/Francais

Shopping Basket

Info Reports Logo

Implants: Tools for Providers



From INFO's Toolbox
October 2007
Issue No. 15
The INFO Project • Johns Hopkins Bloomberg School of Public Health • Center for Communication Programs • 111 Market Place, Suite 310 • Baltimore, Maryland 21202, USA • 410-659-6300 • 410-659-6266 (fax) • www.infoforhealth.orginfoproject@jhuccp.org
Implants: Tools for Providers

Tool: Counseling About Changes in Monthly Bleeding

How to use this tool: Family planning providers can use information from the table below to explain the bleeding changes that new clients can expect.

Bleeding Changes Due to Implants What Might Happen

In the first year users may experience one or more of the following:

After about one year users may experience one or more of the following:

  • Lighter bleeding and fewer days of bleeding
  • Irregular bleeding that lasts more than 8 days*
  • Infrequent bleeding
  • No monthly bleeding
  • Lighter bleeding and fewer days of bleeding
  • Irregular bleeding
  • Infrequent bleeding
  • Even at one year some women have no monthly bleeding

*In the first few months Implanon users are more likely than users of Norplant, Jadelle, or Sino-Implant (II) to have infrequent or no monthly bleeding and less likely to have frequent bleeding. Users of all implants experience irregular bleeding lasting more than 8 days at similar rates. After 1 year there are no significant differences among the various implants.

Norplant, Jadelle, and, Sino-Implant (II) users with lower body weight have fewer bleeding episodes (days of bleeding) and longer bleeding-free intervals than heavier women (12).

Sources: Edwards 1999 (3), Hickey 2002 (7), Han 1999 (6), and Zheng 1999 (18)

Concerns about bleeding changes deserve the provider’s attention. If a continuing user reports side effects or problems, listen to her concerns, give her advice, and, if appropriate, treat. Specific guidance for managing bleeding problems among implant users is available in the Implants chapter of Family Planning: A Global Handbook for Providers, available at: http://www.fphandbook.org

Implants for Women With HIV/AIDS

  • Women who are infected with HIV, have AIDS, or are on antiretroviral (ARV) therapy can safely use implants.

  • Urge these women to use condoms along with implants. Used consistently and correctly, condoms help prevent transmission of HIV and other STIs. Condoms also provide extra contraceptive protection for women on ARV therapy. It is not certain whether ARV medications reduce the effectiveness of implants.

Previous | Next
Top of Page

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.